133 related articles for article (PubMed ID: 35674297)
1. South African (501Y.V2) and the United Kingdom (B.1.1.7) SARS-CoV-2 Spike (S) Protein Variants Demonstrate a Higher Binding Affinity to ACE2.
Mohammad A; Abubaker J; Al-Mulla F
Comb Chem High Throughput Screen; 2023; 26(3):589-594. PubMed ID: 35674297
[TBL] [Abstract][Full Text] [Related]
2. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
Villoutreix BO; Calvez V; Marcelin AG; Khatib AM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580
[TBL] [Abstract][Full Text] [Related]
3. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab
Liu H; Wei P; Zhang Q; Chen Z; Aviszus K; Downing W; Peterson S; Reynoso L; Downey GP; Frankel SK; Kappler J; Marrack P; Zhang G
MAbs; 2021; 13(1):1919285. PubMed ID: 34074219
[TBL] [Abstract][Full Text] [Related]
4. Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Ibrahim IM; Elfiky AA; Elgohary AM
Biochem Biophys Res Commun; 2021 Jul; 562():89-93. PubMed ID: 34049205
[TBL] [Abstract][Full Text] [Related]
5. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2).
Istifli ES; Netz PA; Sihoglu Tepe A; Sarikurkcu C; Tepe B
J Biomol Struct Dyn; 2022; 40(23):12760-12771. PubMed ID: 34495817
[TBL] [Abstract][Full Text] [Related]
7. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.
Khan A; Zia T; Suleman M; Khan T; Ali SS; Abbasi AA; Mohammad A; Wei DQ
J Cell Physiol; 2021 Oct; 236(10):7045-7057. PubMed ID: 33755190
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
Li Q; Nie J; Wu J; Zhang L; Ding R; Wang H; Zhang Y; Li T; Liu S; Zhang M; Zhao C; Liu H; Nie L; Qin H; Wang M; Lu Q; Li X; Liu J; Liang H; Shi Y; Shen Y; Xie L; Zhang L; Qu X; Xu W; Huang W; Wang Y
Cell; 2021 Apr; 184(9):2362-2371.e9. PubMed ID: 33735608
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries.
Wang R; Chen J; Gao K; Wei GW
Genomics; 2021 Jul; 113(4):2158-2170. PubMed ID: 34004284
[TBL] [Abstract][Full Text] [Related]
10. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
[TBL] [Abstract][Full Text] [Related]
11. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
12. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
[TBL] [Abstract][Full Text] [Related]
13. In silico investigations of heparin binding to SARS-CoV-2 variants with a focus at the RBD/ACE2 interface.
Ali N; Khan R; AlAsmari AF; Kumar V
Process Biochem; 2022 Apr; 115():70-79. PubMed ID: 35194375
[TBL] [Abstract][Full Text] [Related]
14. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
[TBL] [Abstract][Full Text] [Related]
15. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
bioRxiv; 2021 Aug; ():. PubMed ID: 34462749
[TBL] [Abstract][Full Text] [Related]
16. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.
Laffeber C; de Koning K; Kanaar R; Lebbink JHG
J Mol Biol; 2021 Jul; 433(15):167058. PubMed ID: 34023401
[TBL] [Abstract][Full Text] [Related]
17. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
Cele S; Gazy I; Jackson L; Hwa SH; Tegally H; Lustig G; Giandhari J; Pillay S; Wilkinson E; Naidoo Y; Karim F; Ganga Y; Khan K; Bernstein M; Balazs AB; Gosnell BI; Hanekom W; Moosa MS; ; ; Lessells RJ; de Oliveira T; Sigal A
Nature; 2021 May; 593(7857):142-146. PubMed ID: 33780970
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
[TBL] [Abstract][Full Text] [Related]
19. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
